Diaz-BuxoJ.A.CCPD is even better than CAPD.Kidney Int.1985; 28: S26–28.
14.
Mat ternW.D., MorrisC.R., HefHeyD.L.A three-year experience with CCPD in a university-based dialysis and transplantation program.Clin Nephrol.1988; 30: S49–52.
15.
NolphK.D.The current status of CAPD and CCPD.Dial Transplant.1988; 9: 457–460.
16.
Diaz-BuxoJ.A.Does CCPD lower the peritonitis rate? In: BerlyneG.M., GiovannettiS., AugustinR., eds. Peritonitis in CAPD.Basel, Switzerland: Karger. Contr Nephrol; 1987: 191–196.
17.
CavorettoC.A., JacksonF.E.A decrease in peritonitis with CCPD-One unit's experience.Nephrol Nurse.1983; 5: 33–37.
18.
National CAPD Registry of the National Institutes of Health, Bethesda, Maryland, 1987.
VergerC., LuzarM.A.In vitro study of CAPD Y-Iine system. In: KhannaR., NolphK.D., ProwantB., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin; 1986: 160–164.
21.
VergerC., FallerB., RyckelynckJ.P.H., CamG., PierreD.Comparison between the efficacy of CAPD Y-lines without “in line” disinfectant and standard systems: A multicenter prospective controlled trial.Perit Dial Bull.1987; 7: S82.
22.
MaiorcaR., CancariniG.C., BroccoliR.Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis.Lancet1983; 2: 642–644.
23.
CantaluppiA., ScalamognaA., CastelnovoC., GrazianiG.Long-term efficacy of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. In: KhannaR., NolphK.D., ProwantB., TwardowskiZ.J., OreopoulosD.G., eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin; 1986: 183–185.
Diaz-BuxoJ.A.The importance of the peritoneal equilibration test-A plea for uniformity.Perit Dial Bull.1987; 7: 118.
32.
TwardowskiZ.J., KhannaR., NolphK.D.Peritoneal dialysis modifications to avoid CAPD drop out. In: KhannaR., NolphK.D., ProwantB., TwardowskiZ.J., OreopoulosD.G., eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin; 1987: 171–178.
33.
Diaz-BuxoJ.A.Peritoneal permeability and the selection of peritoneal dialysis modalities.Perspect Perit Dial.1988; 5: 6–10.
34.
TwardowskiZ.J., NolphK.D., KhannaR., GluckZ., ProwantB.F., RyanL.P.Daily clearances with continuous ambulatory and nightly peritoneal dialysis.Trans Am Soc Artif Intern Organs1986; 32: 575–580.
35.
Diaz-BuxoJ.A.Inadequacy of dialysis-A preventable cause of drop out. In: La GrecaG., ChiaramonteS., FabrisA., FerianiM., Ronco, eds. Peritoneal dialysis.Milano: Wichtig Editore; 1988: 181–185.
36.
BlumenkrantzM.J., GordonA., RobertsM.Applications of the Redy Sorbent System to hemodialysis and peritoneal dialysis.Artif Organs.1979; 3: 230–236.
37.
StephenR.L.Reciprocating peritoneal dialysis with a subcutaneous peritoneal catheter.Dial Transplant.1978; 7: 834.
38.
TenckhoffH., WardG., BoenS.T.The influence of dialysate volume and flow rate on peritoneal clearances.Proc Eur Dial Transplant Assoc.1965; 2: 113.
OrenA., WuG., AndersonG.H.Effective use of amino acid dialysate over four weeks in CAPD patients.Perit Dial Bull.1983; 3: 66–73.
41.
OreopoulosD.G., BalfeJ.W., KhannaR.Further experience with the use of amino acid containing dialysate (Amino-Dianeal) in peritoneal dialysis. In: MoncriefJ.W., PopovichR.W., eds. CAPD update-Continuous ambulatory peritoneal dialysis.New York: Masson Publishing;1980: 109.
42.
WilliamsP.F., MarlissE., AndersonG.H.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull.1982; 2: 124–130.
43.
FerianiM., BiasioliS., BorinD.Bicarbonate buffer for peritoneal dialysis: Dream or reality? In: La GrecaG.., eds. Peritoneal dialysis.Milano: Wichtig Editore; 1985: 143–148.
44.
IngT.S., GandhiV.C., DaugirdasJ.T., HuntJ., QuonM.J., RopliS.Peritoneal dialysis using bicarbonate-containing dialysate produced by automated dialysate delivery system.Artif Organs.1982; 6: 67–69.
45.
MactierR.A., KhannaR., TwardowskiZ.J.Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in CAPD.J Clin Invest.1987; 80: 1311–1316.
46.
NolphK.D., MactierR.A., KhannaR.Kinetics of peritoneal ultrafiltration: The role of lymphatics.Kidney Int.1987; 32: 219–226.
47.
MactierR.A., KhannaR., MooreH.Reduction of lymphatic absorption from the peritoneal cavity with intraperitoneal neostigmine, phosphatidylcholine and other drugs. In: La GrecaG., ChiaramonteS., FabrisA.., eds. Peritoneal Dialysis.Milano: Wichtig Editore; 1988: 41–44.